Author Correction: Suppression of Glioblastoma by a Drug Cocktail Reprogramming Tumor Cells into Neuronal Like Cells

Lei Gao,Shichao Huang,Hong Zhang,Wei Hua,Shunmei Xin,Lin Cheng,Wuqiang Guan,Yongchun Yu,Ying Mao,Gang Pei

DOI: https://doi.org/10.1038/s41598-020-59777-8

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

What problem does this paper attempt to address?

Author Correction: Selective, high-contrast detection of syngeneic glioblastoma in vivo

Richard B. Banati,Paul Wilcox,Ran Xu,Grace Yin,Emily Si,Eric Taeyoung Son,Mauricio Shimizu,R. M. Damian Holsinger,Arvind Parmar,David Zahra,Andrew Arthur,Ryan J. Middleton,Guo-Jun Liu,Arnaud Charil,Manuel B. Graeber

DOI: https://doi.org/10.1038/s41598-020-72364-1

IF: 4.6

2020-09-24

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Suppression of Glioblastoma by a Drug Cocktail Reprogramming Tumor Cells into Neuronal Like Cells

Gao, Longfei,Huang, Shichao,Zhang, Hong,Hua, Wei,Xin, Shunmei,Cheng, Lin,Guan, Wuqiang,Yu, Yongchun,Mao, Ying,Pei, Gang

DOI: https://doi.org/10.1038/s41598-019-39852-5

IF: 4.6

2019-01-01

Scientific Reports

Abstract:Glioblastoma (GBM) is the most common and aggressive malignant tumor in adult brain. Even with the current standard therapy including surgical resection followed by postoperative radiotherapy and chemotherapy with temozolomide (Temo), GBM patients still have a poor median survival. Reprogramming of tumor cells into non-malignant cells might be a promising therapeutic strategy for malignant tumors, including GBM. Based on previous studies using small molecules to reprogram astrocytes into neuronal cells, here we further identified a FTT cocktail of three commonly used drugs (Fasudil, Tranilast, and Temo) to reprogram patient-derived GBM cells, either cultured in serum containing or serum-free medium, into neuronal like cells. FTT-treated GBM cells displayed a neuronal like morphology, expressed neuronal genes, exhibited neuronal electrophysiological properties, and showed attenuated malignancy. More importantly, FTT cocktail more significantly suppressed tumor growth and prolonged survival in GBM patient derived xenograft than Temo alone. Our study provided preclinical evidence that the neuronal reprogramming drug cocktail might be a promising strategy to improve the existing treatment for GBM.
Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Xiu-Ying He,Yang Xu,Qing-Jie Xia,Xiao-Ming Zhao,Shan Li,Xiao-Qiong He,Ru-Rong Wang,Ting-Hua Wang

DOI: https://doi.org/10.3389/fonc.2022.872110

IF: 4.7

2022-03-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.663262.].

oncology
Author Correction: Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth

Rossella Delle Donne,Rosa Iannucci,Laura Rinaldi,Luca Roberto,Maria A. Oliva,Emanuela Senatore,Domenica Borzacchiello,Luca Lignitto,Giorgio Giurato,Francesca Rizzo,Assunta Sellitto,Francesco Chiuso,Salvatore Castaldo,Giovanni Scala,Virginia Campani,Valeria Nele,Giuseppe De Rosa,Chiara D'Ambrosio,Corrado Garbi,Andrea Scaloni,Alessandro Weisz,Concetta Ambrosino,Antonella Arcella,Antonio Feliciello

DOI: https://doi.org/10.1038/s42003-024-07075-8

IF: 6.548

2024-10-31

Communications Biology

Abstract:Communications Biology, Published online: 29 October 2024; doi:10.1038/s42003-024-07075-8 Author Correction: Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth

biology
Correction: Dong et al. Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation. Cells 2022, 11, 3302

Lei Dong,Yang Li,Liqun Liu,Xinyi Meng,Shengzhen Li,Da Han,Zhenyu Xiao,Qin Xia

DOI: https://doi.org/10.3390/cells13181575

IF: 6

2024-09-20

Cells

Abstract:Cells, Vol. 13, Pages 1575: Correction: Dong et al. Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation. Cells 2022, 11, 3302 Cells doi: 10.3390/cells13181575 Authors: Lei Dong Yang Li Liqun Liu Xinyi Meng Shengzhen Li Da Han Zhenyu Xiao Qin Xia In the original publication [...]

cell biology
Author Correction: A Next-Generation Tumor-Targeting IL-2 Preferentially Promotes Tumor-Infiltrating CD8+ T-cell Response and Effective Tumor Control

Zhichen Sun,Zhenhua Ren,Kaiting Yang,Zhida Liu,Shuaishuai Cao,Sisi Deng,Lily Xu,Yong Liang,Jingya Guo,Yingjie Bian,Hairong Xu,Jiyun Shi,Fan Wang,Yang-Xin Fu,Hua Peng

DOI: https://doi.org/10.1038/s41467-020-15532-1

IF: 16.6

2020-01-01

Nature Communications

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M + diffuse midline gliomas

Michelle Monje,Jasia Mahdi,Robbie Majzner,Kristen W. Yeom,Liora M. Schultz,Rebecca M. Richards,Valentin Barsan,Kun-Wei Song,Jen Kamens,Christina Baggott,Michael Kunicki,Skyler P. Rietberg,Alexandria Sung Lim,Agnes Reschke,Sharon Mavroukakis,Emily Egeler,Jennifer Moon,Shabnum Patel,Harshini Chinnasamy,Courtney Erickson,Ashley Jacobs,Allison K. Duh,Ramya Tunuguntla,Dorota Danuta Klysz,Carley Fowler,Sean Green,Barbara Beebe,Casey Carr,Michelle Fujimoto,Annie Kathleen Brown,Ann-Louise G. Petersen,Catherine McIntyre,Aman Siddiqui,Nadia Lepori-Bui,Katlin Villar,Kymhuynh Pham,Rachel Bove,Eric Musa,Warren D. Reynolds,Adam Kuo,Snehit Prabhu,Lindsey Rasmussen,Timothy T. Cornell,Sonia Partap,Paul G. Fisher,Cynthia J. Campen,Gerald Grant,Laura Prolo,Xiaobu Ye,Bita Sahaf,Kara L. Davis,Steven A. Feldman,Sneha Ramakrishna,Crystal Mackall

DOI: https://doi.org/10.1038/s41586-024-08452-3

IF: 64.8

2024-11-30

Nature

Abstract:Nature - Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas

multidisciplinary sciences
Author Correction: Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling

Chuanhui Han,Zhida Liu,Yunjia Zhang,Aijun Shen,Chunbo Dong,Anli Zhang,Casey Moore,Zhenhua Ren,Changzheng Lu,Xuezhi Cao,Chun-Li Zhang,Jian Qiao,Yang-Xin Fu

DOI: https://doi.org/10.1038/s41590-020-00805-0

IF: 30.5

2020-09-16

Nature Immunology

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

immunology
Correction to: LTBP1 plays a potential bridge between depressive disorder and glioblastoma

Xiaojun Fu,Pei Zhang,Hongwang Song,Chenxing Wu,Shengzhen Li,Shouwei Li,Changxiang Yan

DOI: https://doi.org/10.1186/s12967-020-02619-y

IF: 8.44

2020-11-27

Journal of Translational Medicine

Abstract:An amendment to this paper has been published and can be accessed via the original article.

medicine, research & experimental
Correction to: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/Glioblastomas

Queenie Hoi-Wing Wong,Kay Ka-Wai Li,Wei-Wei Wang,Tathiane M. Malta,Houtan Noushmehr,Yura Grabovska,Chris Jones,Aden Ka-Yin Chan,Johnny Sheung-Him Kwan,Queenie Jun-Qi Huang,Gabriel Chun-Hei Wong,Wen-Cai Li,Xian-Zhi Liu,Hong Chen,Danny Tat-Ming Chan,Ying Mao,Zhen-Yu Zhang,Zhi-Feng Shi,Ho-Keung Ng

DOI: https://doi.org/10.1038/s41379-021-00802-0

IF: 8.209

2021-04-15

Modern Pathology

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41379-021-00802-0

pathology
Retraction Note: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors

Jie Yuan,Fan Zhang,Dennis Hallahan,Zhen Zhang,Liming He,Ling-Gang Wu,Meng You,Qin Yang

DOI: https://doi.org/10.1186/s13046-021-02172-6

2021-11-18

Abstract:This article has been retracted. Please see the Retraction Notice for more detail: 10.1186/s13046-021-02172-6

oncology
Author Correction: Autophagy Inhibition Sensitizes Hepatocellular Carcinoma to the Multikinase Inhibitor Linifanib

Hongming Pan,Zhanggui Wang,Liming Jiang,Xinbing Sui,Liangkun You,Jiawei Shou,Zhao Jing,Jiansheng Xie,Weiting Ge,Xiujun Cai,Wendong Huang,Weidong Han

DOI: https://doi.org/10.1038/s41598-020-74205-7

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Author Correction: A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis

Yanzhe Gao,Elizabeth Mutter-Rottmayer,Alicia M. Greenwalt,Dennis Goldfarb,Feng Yan,Yang Yang,Raquel C. Martinez-Chacin,Kenneth H. Pearce,Satoshi Tateishi,Michael B. Major,Cyrus Vaziri

DOI: https://doi.org/10.1038/s41467-024-54248-4

IF: 16.6

2024-11-18

Nature Communications

Abstract:Nature Communications, Published online: 14 November 2024; doi:10.1038/s41467-024-54248-4 Author Correction: A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis

multidisciplinary sciences
Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness

Ming-Jenn Chen,De-Wei Wu,Yao-Chen Wang,Chi-Yi Chen,Huei Lee

DOI: https://doi.org/10.1038/s41598-020-74206-6

IF: 4.6

2020-10-23

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Corrigendum: 5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells

Xuehua Zhang,Leilei Zhao,Jinlong Xiao,Yudi Wang,Yunmeng Li,Chaoqun Zhu,He Zhang,Yurui Zhang,Xiao Zhu,Yucui Dong

DOI: https://doi.org/10.3389/fonc.2024.1494738

IF: 4.7

2024-10-01

Frontiers in Oncology

Abstract:This article is a correction to: 5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells

oncology
Author Correction: Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Hao Qian,Xinjiang Kang,Jing Hu,Dongyang Zhang,Zhengyu Liang,Fan Meng,Xuan Zhang,Yuanchao Xue,Roy Maimon,Steven F. Dowdy,Neal K. Devaraj,Zhuan Zhou,William C. Mobley,Don W. Cleveland,Xiang-Dong Fu

DOI: https://doi.org/10.1038/s41586-020-2583-3

IF: 64.8

2020-07-29

Nature

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models

Chun-Ting Kuo,Chen-Lin Chen,Chih-Chi Li,Guan-Syuan Huang,Wei-Yuan Ma,Wei-Fan Hsu,Ching-Hung Lin,Yen-Shen Lu,Andrew M. Wo

DOI: https://doi.org/10.1038/s41598-020-68553-7

IF: 4.6

2020-08-19

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Publisher Correction: ‘TRAIL-based gene delivery and therapeutic strategies’ and ‘Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy’

Hui-ha Zhong,Hui-yuan Wang,Jian Gao,Yong-zhuo Huang,Ang Gao,Xian-li Hu,Madiha Saeed,Bin-fan Chen,Ya-ping Li,Hai-jun Yu

DOI: https://doi.org/10.1038/s41401-020-0444-0

IF: 7.169

2020-07-06

Acta Pharmacologica Sinica

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

pharmacology & pharmacy,chemistry, multidisciplinary
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

Zhuolong Zhou,Kevin Van der Jeught,Yuanzhang Fang,Tao Yu,Yujing Li,Zheng Ao,Sheng Liu,Lu Zhang,Yang Yang,Haniyeh Eyvani,Mary L. Cox,Xiyu Wang,Xiaoming He,Guang Ji,Bryan P. Schneider,Feng Guo,Jun Wan,Xinna Zhang,Xiongbin Lu

DOI: https://doi.org/10.1038/s41551-023-01096-0

IF: 28.1

2023-08-31

Nature Biomedical Engineering

Abstract:Nature Biomedical Engineering, Published online: 30 August 2023; doi:10.1038/s41551-023-01096-0 Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

engineering, biomedical

Author Correction: Suppression of Glioblastoma by a Drug Cocktail Reprogramming Tumor Cells into Neuronal Like Cells

Author Correction: Selective, high-contrast detection of syngeneic glioblastoma in vivo

Suppression of Glioblastoma by a Drug Cocktail Reprogramming Tumor Cells into Neuronal Like Cells

Corrigendum: Combined Scutellarin and C18H17NO6 Imperils the Survival of Glioma: Partly Associated With the Repression of PSEN1/PI3K-AKT Signaling Axis

Author Correction: Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth

Correction: Dong et al. Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation. Cells 2022, 11, 3302

Author Correction: A Next-Generation Tumor-Targeting IL-2 Preferentially Promotes Tumor-Infiltrating CD8+ T-cell Response and Effective Tumor Control

Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M + diffuse midline gliomas

Author Correction: Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling

Correction to: LTBP1 plays a potential bridge between depressive disorder and glioblastoma

Correction to: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/Glioblastomas

Retraction Note: Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors

Author Correction: Autophagy Inhibition Sensitizes Hepatocellular Carcinoma to the Multikinase Inhibitor Linifanib

Author Correction: A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis

Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness

Corrigendum: 5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells

Author Correction: Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models

Publisher Correction: ‘TRAIL-based gene delivery and therapeutic strategies’ and ‘Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy’

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity